Acadian Asset Management’s Larimar Therapeutics LRMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $113K | Buy |
|
|||||
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $103K | Sell |
|
|||||
|
2023
Q3 | $141K | Sell |
|
|||||
|
2023
Q2 | $397K | Buy |
|
|||||
|
2023
Q1 | $331K | Buy |
|
|||||
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $4K | Buy |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $259K | Buy |
|
|||||
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $131K | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $389K | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $92K | Sell |
|
|||||
|
2018
Q2 | $502K | Sell |
|
|||||
|
2018
Q1 | $534K | Sell |
|
|||||
|
2017
Q4 | $481K | Buy |
|
|||||
|
2017
Q3 | $310K | Buy |
|
|||||
|
2017
Q2 | $304K | Buy |
|